Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 27 - Drugs for disorders of the senses
Patents for A61P 27 - Drugs for disorders of the senses (53,017)
11/2010
11/11/2010US20100286029 Use of a peptide as a therapeutic agent
11/11/2010US20100285155 Cleanser composition and methods for using the same
11/11/2010US20100285009 Humanized anti-egfl7 antibodies and methods using same
11/11/2010US20100284922 Marker
11/11/2010CA2838400A1 Humanized anti-egfl7 antibodies and methods using same
11/10/2010EP2248825A1 Antigen binding fragments of an antibody for use in treating and diagnosing ocular diseases
11/10/2010EP2248521A1 Inhibitors of jun n-terminal kinases for treating glaucomatous retinopathy and ocular diseases
11/10/2010EP2247584A1 Fused pyridines active as inhibitors of c-met
11/10/2010EP2247583A1 Hydrazines in glaucoma therapy
11/10/2010EP2247289A2 Ophthalmic nsaids as adjuvants
11/10/2010EP1643997B1 Flupirtine preparation for treating neurodegenerative disorders of the visual system and diabetes mellitus
11/10/2010EP1513589B1 1,5-disubstituted pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma
11/10/2010CN201625211U Tablet capsule filled with Dihydroergocryptine mesylate A tablet and caffeine tablet
11/10/2010CN1980889B Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
11/10/2010CN1824059B Use of nutritive product for preventing and treating nightblindness
11/10/2010CN1635882B Use of composition in preparing medicine for treating hearing loss
11/10/2010CN101883790A Use of anti-amyloid beta antibody in ocular diseases
11/10/2010CN101883765A Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same
11/10/2010CN101880283A Azaindole kinase inhibitors
11/10/2010CN101879258A Chinese herbal composite eye drop for preventing and curing infection lesion of eyeballs
11/10/2010CN101879249A Traditional Chinese medicine for treating pinkeye
11/10/2010CN101879239A Traditional Chinese medicine for treating tympanitis
11/10/2010CN101879161A Application of N-[4-(monohydro-pyrazol-4-) phenyl]-2,3-dihydro-1,4-benzdioxan-2-amide derivative in preparing drug for treating glaucoma
11/10/2010CN101337071B Composition for preparing anti-cataract products
11/10/2010CN101249175B Chinese medicine prescription for curing myopic eye disease and production method of preparations
11/10/2010CN101198355B Agent for prevention or treatment of glaucoma
11/09/2010US7829721 Therapy for diabetic retinopathy
11/09/2010US7829573 Therapeutic combinations of antihypertensive and antiangiogenics agents
11/09/2010US7829561 interleukin-1B converting enzyme inhibitors such as 3-(6,11-Dioxo-1,2,3,4-tetrahydro-pyridazino[1,2-b]phthalazin-1-carboxamido)-5-fluoro-4-oxo-pentanoic acid, that mediate cell apoptosis and inflammation, used for cell or organ preservation and the treatment of osteoarthritis and rheumatoid arthritis
11/09/2010US7829534 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
11/09/2010US7827986 Methods for treating jaw pain
11/09/2010CA2493958C Muscarinic agonists
11/09/2010CA2484188C Tachykinin receptor antagonists
11/09/2010CA2462692C Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity
11/09/2010CA2420038C Devices for intraocular drug delivery
11/07/2010CA2665956A1 Combination treatment for ocular diseases
11/04/2010WO2010127210A1 Method of reducing intraocular pressure in humans
11/04/2010WO2010126911A1 Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
11/04/2010WO2010126909A1 Formulation of tocotrienol quinones for the treatment of ophthalmic diseases
11/04/2010WO2010126169A1 Pharmaceutical composition for preventing vascular disorders which comprises alk1 inhibitor as active ingredient
11/04/2010WO2010126104A1 4-substituted pyridazinone compound and p2x7 receptor inhibitor
11/04/2010WO2010126034A1 Novel compound, histone acetylase inhibitor, nuclear receptor transcription activation inhibitor, deuteromycetes belonging to genus penicillium, and production process
11/04/2010WO2010126022A1 Imidazole derivative
11/04/2010WO2010125799A1 Urea derivative having pi3k inhibitory activity
11/04/2010WO2010125516A1 Compositions containing a mixture of lutein and zeaxanthine and coated with chocolate
11/04/2010WO2010125445A1 Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders
11/04/2010WO2010125416A1 Drug delivery to the anterior and posterior segments of the eye
11/04/2010WO2010124521A1 Derivatives of rhein, preparation methods and uses thereof
11/04/2010US20100280249 Synthesis of 4-amino-thalidomide enantiomers
11/04/2010US20100280089 Use of inhibitors of jun n-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
11/04/2010US20100280079 0novel, 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators
11/04/2010US20100280076 Derivatives of dioxan-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
11/04/2010US20100280073 Tricyclic inhibitors of hydroxysteroid dehydrogenases
11/04/2010US20100280065 Perharidines as cdk inhibitors
11/04/2010US20100280051 Use of allopurinol for the treatment of hand foot skin reaction
11/04/2010US20100280032 Method for treating inflammatory disorders
11/04/2010US20100280018 Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors
11/04/2010US20100279991 Tetrahydro-cyclopentyl pyrazole cannabinoid modulators
11/04/2010US20100279981 Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid
11/04/2010US20100279970 Method of reducing intraocular pressure in humans
11/04/2010US20100279961 Pharmaceutical composition having a trihydroxy-chromenone derivative
11/04/2010US20100279951 Method of treating allergic conjunctivitis with cyclosporin compositions
11/04/2010US20100279406 Alteration of tumor growth using zinc finger proteins
11/04/2010US20100278931 Porous silicon drug-eluting particles
11/04/2010US20100278914 Fraction of melissa leaf extract having angiogenesis and mmp inhibitory activities, and composition comprising the same
11/04/2010US20100278897 Intraocular bioactive agent delivery system with molecular partitioning system
11/04/2010US20100278811 Vasculostatic agents and methods of use thereof
11/04/2010US20100278776 Pharmaceutical compositions for modulating a kinase cascade and methods of use thereof
11/04/2010CA2777479A1 Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
11/04/2010CA2762064A1 Method of reducing intraocular pressure in humans
11/04/2010CA2760591A1 Cleanser compositions and methods for using the same
11/04/2010CA2760562A1 Dual mechanism inhibitors for the treatment of disease
11/04/2010CA2760357A1 Topical, periocular, or intraocular use of tocotrienols for the treatment of ophthalmic diseases
11/04/2010CA2760253A1 Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders
11/04/2010CA2759984A1 Formulation of tocotrienol quinones for the treatment of ophthalmic diseases
11/04/2010CA2748892A1 A process for the isolation of carotenoids crystals from different plants
11/03/2010EP2246327A1 A process for isolation of lutein and zeaxanthin crystals from plant sources
11/03/2010EP2245005A1 Substituted cyclopentanes having prostaglandin activity
11/03/2010EP1951725B1 N-sulfamoyl-n -benzopyranpiperidines as inhbitors of carbonic anhydrases
11/03/2010EP1556080B1 Furin inhibitors for use in the treatment of fibrosis and scarring
11/03/2010EP1296929B1 Modified forms of pharmacologically active agents and uses therefor
11/03/2010EP1268760B1 Recombinant proteins containing shiga-like toxin and vascular endothelial growth factor fragments
11/03/2010EP0719273B1 Nucleotide analogs
11/03/2010CN1850062B Fatty acid eye nano preparations for dry eye disease
11/03/2010CN101878026A Pharmacological adjunctive treatment associated with glaucoma filtration surgery
11/03/2010CN101874811A Preparation method of silica modified nano pearl powder
11/03/2010CN101874787A Riboflavin sodium phosphate freeze-dried powder injection and preparation method thereof
11/02/2010US7825146 Sulfonamide derivative having isoxazole ring
11/02/2010US7825129 Thieno[2,3-c] isoquinolines for use as inhibitors of PARP
11/02/2010US7825114 Substituted aminopyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
11/02/2010US7825105 such as 3,10-Dibenzyloxyminocycline, used to treat bacterial infections and neoplasms, as well as blocking tetracycline efflux and modulation of gene expression
11/02/2010US7824860 Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH)
11/02/2010CA2462799C Pyrimidine derivatives
11/02/2010CA2460121C 3-substituted-4-pyrimidone derivatives
11/02/2010CA2439784C Pyrazolopyrimidinone derivatives having pde7 inhibiting action
11/02/2010CA2437715C Carboline derivatives
11/02/2010CA2383293C Anti-infective compositions for treating disordered tissue such as cold sores
10/2010
10/28/2010WO2010123769A1 Compositions and methods for treating ocular inflammation with lower risk of increased intraocular pressure
10/28/2010WO2010123156A1 Angiogenesis inhibitor
10/28/2010US20100273894 Treatment of leber's hereditary optic neuropathy and dominant optic atrophy with tocotrienol quinones
1 ... 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 ... 531